Skip to main content
. 2009 Sep 18;468(3):867–874. doi: 10.1007/s11999-009-1099-9

Table 3.

Fractions of bone in gap and on the implant surface

Dose (mg zoledronate/mL) Gap (%) Surface (%)
New bone Allograft New bone Allograft
Control (0 mg/mL) 12 (8–14) 19 (16–21) 3 (1–12) 1 (0–1)
Low dose (0.005 mg/mL) 20 (19–23) 35 (31–39) 2 (0–2) 1 (0–1)
Middle dose (0.05 mg/mL) 11 (8–14) 44 (40–46) 1 (0–3) 5 (3–7)
High dose (0.5 mg/mL) 0 (0–0) 43 (40–47) 0 (0–0) 6 (5–8)

Values are expressed as medians with interquartile ranges in parentheses.